logo for PFE

PFE • NYSE

Pfizer Inc.

$24.85

+ Add to Watchlist

Stock Details

Market Cap 141,289,832,667
Day Change 0.24 (0.98%)
Volume 123,871,028
Avg Volume 55,445,534
Price Range 20.92-27.69

Overview

Country US
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NYSE

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Financial Overview

52 Week High 28.54
52 Week High Date 2024-11-01
52 Week Low 20.915
52 Week Low Date 2025-04-09
10D Avg Trading Vol 85.80864
YTD Price Return Daily -8.4056
MTD Price Return Daily -1.4199

Cash Flow

TTM/Share 2.91656
Annual/Share 1.7355
Quarterly/Share 1.8248

Price-to-Earnings

Annual Ratio 1.1713
Quarterly Ratio 1.2822
TTM 14.3112

Revenue

3Y Growth -7.84
5Y Growth 9.1
Annual/Share -5.91
TTM/Share 10.9881
5Y Share Growth 9

Earnings Per Share

Annual 1.4089
3Y Growth -28.48
5Y Growth -13.25
Quarterly YOY Growth -20.82

Price-to-Book

Ratio 1.5158
Annual Ratio 1.7045
TTM 1.4612